Jingli Xu Selected Research

Bombesin

7/2018	Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer.
2/2015	Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingli Xu Research Topics

Disease

24	Neoplasms (Cancer) 05/2024 - 08/2009
13	Melanoma (Melanoma, Malignant) 05/2023 - 04/2015
9	Stomach Neoplasms (Stomach Cancer) 05/2024 - 01/2022
4	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2020
4	Brain Neoplasms (Brain Tumor) 07/2012 - 08/2009
3	Prostatic Neoplasms (Prostate Cancer) 07/2018 - 02/2015
2	Glioblastoma (Glioblastoma Multiforme) 07/2018 - 02/2015
1	Arteriovenous Fistula 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Cicatrix (Scar) 04/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2017

Drug/Important Bio-Agent (IBA)

14	Peptides (Polypeptides)IBA 05/2023 - 02/2015
10	LactamsIBA 05/2023 - 10/2016
10	AcidsIBA 05/2023 - 04/2010
9	alpha-MSHIBA 05/2023 - 04/2015
7	Type 1 Melanocortin ReceptorIBA 02/2022 - 11/2018
6	triazacyclononaneIBA 05/2023 - 01/2020
5	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 05/2023 - 01/2020
4	Melanocyte-Stimulating Hormones (MSH)IBA 01/2023 - 11/2019
4	(18F)fluoroethyltyrosineIBA 07/2012 - 08/2009
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2023 - 01/2022
3	pyrimidineIBA 03/2012 - 11/2010
2	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2023
2	IronIBA 01/2023 - 01/2022
2	phenylalanylarginineIBA 01/2023 - 12/2020
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2022 - 02/2015
2	Chelating AgentsIBA 12/2020 - 01/2020
2	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 12/2020 - 01/2020
2	IntegrinsIBA 07/2018 - 02/2015
2	BombesinIBA 07/2018 - 02/2015
2	RadiopharmaceuticalsIBA 02/2015 - 11/2010
2	compound 18IBA 08/2011 - 04/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2023
1	Glutathione PeroxidaseIBA 06/2023
1	KynurenineIBA 06/2023
1	Glutathione (Reduced Glutathione)IBA 06/2023
1	Ribosomal DNA (rDNA)IBA 03/2023
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023
1	omega-aminocaprylic acidIBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 02/2022
1	AlbuminsIBA 02/2022
1	SynteninsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	1-Butanol (n Butanol)IBA 01/2022
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2022
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2022
1	huaierIBA 01/2022
1	MetalsIBA 01/2020
1	terphenyllinIBA 01/2020
1	Radioisotopes (Radionuclides)IBA 11/2018
1	OxidesIBA 04/2018
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2017
1	AntigensIBA 10/2017
1	arginyl-glycyl-aspartic acidIBA 04/2015
1	Bombesin Receptors (Bombesin Receptor)IBA 02/2015
1	LigandsIBA 02/2015
1	QuinazolinesIBA 09/2013
1	Mechlorethamine (Nitrogen Mustard)FDA Link 09/2013
1	Sorafenib (BAY 43-9006)FDA Link 09/2013
1	4-aminoquinazolineIBA 07/2012
1	benzimidazoleIBA 04/2010
1	Butyric Acid (Butanoic Acid)IBA 04/2010
1	Tyrosine (L-Tyrosine)FDA Link 08/2009

Therapy/Procedure

8	Therapeutics 01/2023 - 02/2015
2	Neoadjuvant Therapy 07/2023 - 02/2022
2	Precision Medicine 01/2022 - 07/2018
2	Intravenous Injections 07/2018 - 02/2015
1	Perioperative Period 02/2022
1	Immunotherapy 01/2022
1	Renal Dialysis (Hemodialysis) 01/2020
1	Local Anesthesia 01/2020